FibroBiologics(FBLG)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FBLG FibroBiologics

休市中 07-11 16:00:00 EDT

0.6293

-0.0197

-3.04%

盘后0.6294

+0.0001+0.02%

19:51 EDT

最高0.6797	最低0.6138	成交量31.39万
今开0.6700	昨收0.6490	日振幅10.15%
总市值2,469万	流通市值1,851万	总股本3,924万
成交额19.90万	换手率1.07%	流通股本2,942万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FBLG","market":"US","secType":"STK","nameCN":"FibroBiologics","latestPrice":0.6293,"timestamp":1752264000000,"preClose":0.649,"halted":0,"volume":313869,"hourTrading":{"tag":"盘后","latestPrice":0.6294,"preClose":0.6293,"latestTime":"19:51 EDT","volume":14213,"amount":9102.6659,"timestamp":1752277872831},"delay":0,"floatShares":29418160,"shares":39241354,"eps":-0.223789,"marketStatus":"休市中","change":-0.0197,"latestTime":"07-11 16:00:00 EDT","open":0.67,"high":0.6797,"low":0.6138,"amount":198975.14962769998,"amplitude":0.101541,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.223789,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"listingDate":1706677200000,"exchange":"NASDAQ","adjPreClose":0.649,"preHourTrading":{"tag":"盘前","latestPrice":0.6797,"preClose":0.649,"latestTime":"09:14 EDT","volume":10306,"amount":6874.9847088999995,"timestamp":1752239651928},"postHourTrading":{"tag":"盘后","latestPrice":0.6294,"preClose":0.6293,"latestTime":"19:51 EDT","volume":14213,"amount":9102.6659,"timestamp":1752277872831},"volumeRatio":0.7092716084653391},"requestUrl":"/m/hq/s/FBLG","defaultTab":"news","newsList":[{"id":"2550966552","title":"Fibrobiologics, Inc.盘中异动 股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550966552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550966552?lang=zh_cn&edition=full","pubTime":"2025-07-12 03:01","pubTimestamp":1752260512,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日03时01分，Fibrobiologics, Inc.股票出现异动，股价快速跳水5.38%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712030152a6a45a3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712030152a6a45a3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2550066624","title":"Fibrobiologics, Inc.盘中异动 大幅下挫6.05%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550066624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550066624?lang=zh_cn&edition=full","pubTime":"2025-07-10 23:38","pubTimestamp":1752161888,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日23时38分，Fibrobiologics, Inc.股票出现波动，股价急速下跌6.05%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710233808953d9e3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710233808953d9e3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2550529653","title":"Fibrobiologics, Inc.盘中异动 早盘快速拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550529653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550529653?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:44","pubTimestamp":1752068642,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时44分，Fibrobiologics, Inc.股票出现异动，股价快速上涨5.09%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214402a4407f27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214402a4407f27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2549558056","title":"Fibrobiologics, Inc.盘中异动 早盘快速上涨5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549558056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549558056?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:33","pubTimestamp":1751895227,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时33分，Fibrobiologics, Inc.股票出现波动，股价急速拉升5.39%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213347979d1801&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213347979d1801&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2548480772","title":"Fibrobiologics, Inc.盘中异动 早盘股价大涨6.01%报0.647美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548480772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548480772?lang=zh_cn&edition=full","pubTime":"2025-07-03 21:41","pubTimestamp":1751550087,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时41分，Fibrobiologics, Inc.股票出现波动，股价快速上涨6.01%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070321412795354d35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070321412795354d35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2546604729","title":"Fibrobiologics, Inc.盘中异动 股价大跌5.48%报0.673美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546604729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546604729?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:50","pubTimestamp":1751053835,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时50分，Fibrobiologics, Inc.股票出现波动，股价快速下挫5.48%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035035952e7988&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035035952e7988&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2546230069","title":"Fibrobiologics, Inc.盘中异动 下午盘大幅上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2546230069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546230069?lang=zh_cn&edition=full","pubTime":"2025-06-25 03:05","pubTimestamp":1750791955,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日03时05分，Fibrobiologics, Inc.股票出现波动，股价急速拉升5.06%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为2.07%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625030555978d3ab7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625030555978d3ab7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2545444858","title":"Fibrobiologics, Inc.盘中异动 股价大涨5.23%报0.732美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545444858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545444858?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:59","pubTimestamp":1750687151,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时59分，Fibrobiologics, Inc.股票出现异动，股价快速拉升5.23%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062321591195281e07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025062321591195281e07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2544142178","title":"Fibrobiologics, Inc.盘中异动 股价大涨7.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544142178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544142178?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:32","pubTimestamp":1750426329,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时32分，Fibrobiologics, Inc.股票出现异动，股价大幅拉升7.23%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213209a4b4bec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213209a4b4bec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2544799015","title":"Fibrobiologics, Inc.盘中异动 临近收盘大幅下跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544799015","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544799015?lang=zh_cn&edition=full","pubTime":"2025-06-18 03:57","pubTimestamp":1750190265,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日03时57分，Fibrobiologics, Inc.股票出现异动，股价急速下挫5.53%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为1.66%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618035745a4aefbcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618035745a4aefbcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2543633834","title":"Fibrobiologics, Inc.盘中异动 急速下跌6.02%报0.820美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543633834","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543633834?lang=zh_cn&edition=full","pubTime":"2025-06-13 21:49","pubTimestamp":1749822567,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日21时49分，Fibrobiologics, Inc.股票出现异动，股价急速下跌6.02%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613214928977e4e1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613214928977e4e1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2542996342","title":"Fibrobiologics, Inc.盘中异动 下午盘快速下跌5.32%报0.895美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542996342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542996342?lang=zh_cn&edition=full","pubTime":"2025-06-11 03:05","pubTimestamp":1749582300,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日03时05分，Fibrobiologics, Inc.股票出现异动，股价大幅下挫5.32%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611030500a4a252fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611030500a4a252fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2542338988","title":"Fibrobiologics, Inc.盘中异动 股价大跌5.39%报0.905美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542338988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542338988?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:48","pubTimestamp":1749476909,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时48分，Fibrobiologics, Inc.股票出现异动，股价快速下跌5.39%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092148299777eaf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092148299777eaf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2541093397","title":"Fibrobiologics, Inc.盘中异动 急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541093397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541093397?lang=zh_cn&edition=full","pubTime":"2025-06-05 01:36","pubTimestamp":1749058609,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日01时36分，Fibrobiologics, Inc.股票出现波动，股价大幅上涨5.26%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605013649a49a3250&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605013649a49a3250&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2540706788","title":"Fibrobiologics, Inc.盘中异动 下午盘股价大涨7.46%报0.820美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540706788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540706788?lang=zh_cn&edition=full","pubTime":"2025-06-04 01:14","pubTimestamp":1748970845,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日01时14分，Fibrobiologics, Inc.股票出现异动，股价急速上涨7.46%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060401140597702a7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060401140597702a7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2540867797","title":"Fibrobiologics, Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540867797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540867797?lang=zh_cn&edition=full","pubTime":"2025-06-03 01:03","pubTimestamp":1748883806,"startTime":"0","endTime":"0","summary":"北京时间2025年06月03日01时03分，Fibrobiologics, Inc.股票出现异动，股价急速拉升5.20%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为2.04%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603010327950bb988&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603010327950bb988&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0},{"id":"2539734832","title":"Fibrobiologics, Inc.盘中异动 早盘急速下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539734832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539734832?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:59","pubTimestamp":1748613576,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时59分，Fibrobiologics, Inc.股票出现异动，股价急速下挫5.33%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为3.76%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530215936a492f694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530215936a492f694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2537940385","title":"Fibrobiologics, Inc.盘中异动 股价大跌5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537940385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537940385?lang=zh_cn&edition=full","pubTime":"2025-05-22 22:29","pubTimestamp":1747924185,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日22时29分，Fibrobiologics, Inc.股票出现波动，股价大幅下跌5.86%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522222945aa2c9702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522222945aa2c9702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2536645643","title":"Fibrobiologics, Inc.盘中异动 急速跳水5.59%报0.860美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536645643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536645643?lang=zh_cn&edition=full","pubTime":"2025-05-20 21:55","pubTimestamp":1747749315,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日21时55分，Fibrobiologics, Inc.股票出现波动，股价快速跳水5.59%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520215516aa2c93fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520215516aa2c93fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"gpt_icon":0},{"id":"2535139603","title":"Fibrobiologics, Inc.盘中异动 早盘快速下跌5.89%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535139603","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535139603?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:31","pubTimestamp":1747402301,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时31分，Fibrobiologics, Inc.股票出现异动，股价快速下挫5.89%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213141aa2c910f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213141aa2c910f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fibrobiologics.com","stockEarnings":[{"period":"1week","weight":0.0283},{"period":"1month","weight":-0.2767},{"period":"3month","weight":-0.2929},{"period":"6month","weight":-0.6653},{"period":"1year","weight":-0.8702},{"period":"ytd","weight":-0.6854}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"FibroBiologics, Inc.最初于2021年4月8日根据德克萨斯州法律成立为有限责任公司，然后于2021年12月14日转变为特拉华州公司。FibroBiologics是一家早期细胞治疗公司，总部位于德克萨斯州休斯顿，开发利用成纤维细胞治疗慢性疾病的创新疗法。该公司的主要重点是启动和推进与成纤维细胞治疗退行性椎间盘疾病、多发性硬化症、癌症、伤口愈合和其他疾病相关的临床前研究和临床阶段FDA试验。","exchange":"NASDAQ","name":"FibroBiologics","nameEN":"FibroBiologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"FibroBiologics(FBLG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供FibroBiologics(FBLG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"FibroBiologics,FBLG,FibroBiologics股票,FibroBiologics股票老虎,FibroBiologics股票老虎国际,FibroBiologics行情,FibroBiologics股票行情,FibroBiologics股价,FibroBiologics股市,FibroBiologics股票价格,FibroBiologics股票交易,FibroBiologics股票购买,FibroBiologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"FibroBiologics(FBLG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供FibroBiologics(FBLG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}